Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Topics

Select Topic

Showing 1,267 results.

Thumbnail for Early Cytarabine Escalation Does Not Improve Short-Term Outcomes Compared With Hydroxyurea-Only Cytoreduction in Hyperleukocytic Acute Myeloid Leukemia: A Real-World Propensity-Matched Analysis

AML - 1478

Early Cytarabine Escalation Does Not Improve Short-Term Outcomes Compared With Hydroxyurea-Only Cytoreduction in Hyperleukocytic Acute Myeloid Leukemia: A Real-World Propensity-Matched Analysis

Akshay Aluri

Poster Presenter: Akshay Aluri

Thumbnail for Multi-Hit TET2 Inactivation Identifies a High-Risk Subgroup Assigned to Favorable or Intermediate Categories by the HARMONY Framework in NPM1-Mutated AML

AML - 1483

Multi-Hit TET2 Inactivation Identifies a High-Risk Subgroup Assigned to Favorable or Intermediate Categories by the HARMONY Framework in NPM1-Mutated AML

Paloma Resende

Poster Presenter: Paloma Resende

Previous 1...28 29 30 31 32 33 34...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Temporal Decline in Early Mortality in Acute Myeloid Leukemia Across Chemotherapy, Hypomethylating Agent, and Venetoclax-Based Therapeutic Eras: A Four-Decade Population-Based Analysis

AML - 1492

Temporal Decline in Early Mortality in Acute Myeloid Leukemia Across Chemotherapy, Hypomethylating Agent, and Venetoclax-Based Therapeutic Eras: A Four-Decade Population-Based Analysis

Shahzaib Maqbool

Poster Presenter: Shahzaib Maqbool

Thumbnail for CRISPR/Cas9-Mediated SHP2 Knockout in Jurkat T Cells Using Neon and MaxCyte Electroporation Platforms: Establishment and Validation of a Model for SHP2-Driven Resistance Mechanisms

AML - 150

CRISPR/Cas9-Mediated SHP2 Knockout in Jurkat T Cells Using Neon and MaxCyte Electroporation Platforms: Establishment and Validation of a Model for SHP2-Driven Resistance Mechanisms

Kashif Ali

Poster Presenter: Kashif Ali

Thumbnail for Age-, Sex-, Race-, and Ethnicity-Dependent Architecture of the AML DriverMutational Landscape: A Real-World Analysis of 5,111 Patients in AACRProject GENIE v18.0

AML - 1509

Age-, Sex-, Race-, and Ethnicity-Dependent Architecture of the AML DriverMutational Landscape: A Real-World Analysis of 5,111 Patients in AACRProject GENIE v18.0

Nency Ganatra

Poster Presenter: Nency Ganatra

Thumbnail for Disseminated Intravascular Coagulation in Adults with Active Acute Promyelocytic Leukemia: A Nationwide Analysis of Demographics, Comorbidities, Complications, and 30-Day Readmission Rates

AML - 1521

Disseminated Intravascular Coagulation in Adults with Active Acute Promyelocytic Leukemia: A Nationwide Analysis of Demographics, Comorbidities, Complications, and 30-Day Readmission Rates

Aishwarya Ramesh

Poster Presenter: Aishwarya Ramesh

Thumbnail for Temporal Changes in AML Survival Across Treatment Eras: A SEER Database Analysis (2000-2022)

AML - 1526

Temporal Changes in AML Survival Across Treatment Eras: A SEER Database Analysis (2000-2022)

Maryam Ali

Poster Presenter: Maryam Ali

Thumbnail for Higher ASXL1 Expression Is Associated With Improved Overall Survival in TP53-Mutated Acute Myeloid Leukemia

AML - 1534

Higher ASXL1 Expression Is Associated With Improved Overall Survival in TP53-Mutated Acute Myeloid Leukemia

Max Bustillo

Poster Presenter: Max Bustillo

Thumbnail for Transfusion Patterns and Clinical Characteristics According to Treatment Strategy in Acute Myeloid Leukemia: A 5-Year Experience at a National Referral Oncology Center in Mexico

AML - 1536

Transfusion Patterns and Clinical Characteristics According to Treatment Strategy in Acute Myeloid Leukemia: A 5-Year Experience at a National Referral Oncology Center in Mexico

Janeth Araujo Cardenas

Poster Presenter: Janeth Araujo Cardenas

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors